Sarepta Therapeutics (SRPT) PT Lowered to $175 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Alethia Young lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $175.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
